MetabolicFDA Approved

Tirzepatide (Mounjaro/Zepbound)

Subcutaneous injection (weekly)

Overview

A first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. Tirzepatide activates both incretin pathways simultaneously, producing superior glycemic control and weight loss compared to selective GLP-1 RAs.

Mechanism of Action

The dual mechanism enhances insulin sensitivity and lipid metabolism beyond what either pathway achieves alone..

Research Summary & Key Findings

SURMOUNT-1 trial showed up to 22.5% body weight reduction at highest dose. SURPASS trials demonstrated superior HbA1c reduction vs. semaglutide. FDA-approved for type 2 diabetes (Mounjaro, 2022) and chronic weight management (Zepbound, 2023).

Clinical Status

FDA Approved

Tirzepatide (Mounjaro/Zepbound) has received FDA approval and is available for clinical use under appropriate medical supervision. Consult a qualified healthcare provider for prescribing information.

Administration Routes

Subcutaneous injection (weekly)

Related Peptides in Metabolic

Semaglutide (Ozempic/Wegovy)

FDA Approved

A glucagon-like peptide-1 receptor agonist (GLP-1 RA) with 94% amino acid homology to native GLP-1. Semaglutide enhances...

View details

Retatrutide

In Clinical Trials

An investigational triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. The gluc...

View details

AOD-9604

Investigational

A modified 16-amino acid fragment (amino acids 176-191) of the C-terminus of human growth hormone with an added tyrosine...

View details

Liraglutide (Saxenda/Victoza)

FDA Approved

A GLP-1 receptor agonist with 97% homology to native GLP-1, modified with a fatty acid side chain (C-16 palmitoyl) enabl...

View details

Find a Provider

Find a verified provider who offers Tirzepatide (Mounjaro/Zepbound) therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Tirzepatide (Mounjaro/Zepbound).

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.